Tear fluid proteomics multimarkers for diabetic retinopathy screening

BMC Ophthalmology

Volumn 13, Issue 1, 2013, Pages

  Torok, Zsolt ^a,f   Peto, Tunde ^b   Csosz, Eva ^c   Tukacs, Edit ^a,f   Molnar, Agnes ^d   Maros Szabo, Zsuzsanna ^a,f   Berta, Andras ^e,g   Tozser, Jozsef ^c,g   Hajdu, Andras ^a   Nagy, Valeria ^e   Domokos, Balint ^f   Csutak, Adrienne ^e,g  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f Astridbio Ltd   (Hungary)

^g Inno Tears Ltd   (Hungary)

Author keywords

Diabetic retinopathy screening; Pattern recognition; Quantitative mass spectrometry; Tear fluid biomarkers

Indexed keywords

BIOLOGICAL MARKER; EYE PROTEIN;

ADULT; ALGORITHM; ARTICLE; DIABETIC RETINOPATHY; FEMALE; HUMAN; LACRIMAL FLUID; MALE; METABOLISM; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; DIABETIC RETINOPATHY; EYE PROTEINS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TEARS;

EID: 84881081421     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-13-40     Document Type: Article

References (38)

1. An economic analysis of interventions for diabetes. Klonoff DC, Schwartz DM, Diabetes Care 2000 23 3 390 404 10.2337/diacare.23.3.390 10868871 (Pubitemid 30131750)
2. Diabetic retinopathy. Cheung N, Mitchell P, Wong TY, Lancet 2010 376 9735 124 136 10.1016/S0140-6736(09)62124-3 20580421
3. Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides. Gibbins RL, Owens DR, Allen JC, Eastman L, Diabetologia 1998 41 1 59 64 10.1007/s001250050867 9498631 (Pubitemid 28105742)
4. Sensitivity and specificity of Norwegian optometrists' evaluation of diabetic retinopathy in single-field retinal images, a cross-sectional experimental study. Sundling V, Gulbrandsen P, Straand J, BMC Health Serv Res 2013 13 17 10.1186/1472-6963-13-17 23305337
5. Effectiveness of optometrist screening for diabetic retinopathy using slit-lamp biomicroscopy. Prasad S, Kamath GG, Jones K, Clearkin LG, Phillips RP, Eye (Lond) 2001 15 Pt 5 595 601 (Pubitemid 33014761)
6. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. O'Hare JP, Hopper A, Madhaven C, Charny M, Purewell TS, Harney B, Griffiths J, BMJ 1996 312 7032 679 682 10.1136/bmj.312.7032.679 8597737 (Pubitemid 26085265)
7. Screening for Diabetic Retinopathy, http://www.mrcophth.com/focus1/ Screening%20for%20Diabetic%20Retinopathy.htm
8. The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planning. Harding S, Garvican L, Talbot J, Eye (Lond) 2005 19 9 1009 1011 10.1038/sj.eye.6701751 (Pubitemid 43114983)
9. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Silva PS, Cavallerano JD, Aiello LM, Aiello LP, Arch Ophthalmol 2011 129 2 236 242 10.1001/archophthalmol.2010.365 21320974
10. Diabetic retinopathy screening update. Garg S, Davis RM, Clinical Diabetes 2009 27 4 140 145 10.2337/diaclin.27.4.140
11. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR, Arch Ophthalmol 2011 129 4 435 444 10.1001/archophthalmol.2010.319 21149748
12. A simple diabetes vascular severity staging instrument and its application to a Torres Strait Islander and Aboriginal adult cohort of north Australia. Gibson OR, Segal L, McDermott RA, BMC Health Serv Res 2012 12 185 10.1186/1472-6963-12-185 22759334
13. Manual vs. automated: the diabetic retinopathy screening debate. Sotland GS, Philip S, Fleming AD, Goatman KA, Sharp PF, McNamee P, Prescott GJ, Fonseca S, Olson JA, Ophthalmol Times 2008 4 2
14. Automated detection of diabetic retinopathy: results of a screening study. Bouhaimed M, Gibbins R, Owens D, Diabetes Technol Ther 2008 10 2 142 148 10.1089/dia.2007.0239 18260777 (Pubitemid 351230283)
15. Automated grading for diabetic retinopathy: a large-scale audit using arbitration by clinical experts. Fleming AD, Goatman KA, Philip S, Prescott GJ, Sharp PF, Olson JA, Br J Ophthalmol 2010 94 12 1606 1610 10.1136/bjo.2009.176784 20858722
16. Automated detection of diabetic retinopathy in a fundus photographic screening population. Larsen N, Godt J, Grunkin M, Lund-Andersen H, Larsen M, Invest Ophthalmol Vis Sci 2003 44 2 767 771 10.1167/iovs.02-0417 12556412 (Pubitemid 36159728)
17. Retinopathy online challenge: automatic detection of microaneurysms in digital color fundus photographs. Niemeijer M, van Ginneken B, Cree MJ, Mizutani A, Quellec G, Sanchez CI, Zhang B, Hornero R, Lamard M, Muramatsu C, Wu X, Cazuguel G, You J, Mayo A, Li Q, Hatanaka Y, Cochener B, Roux C, Karray F, Garcia M, Fujita H, Abramoff MD, IEEE Trans Med Imaging 2010 29 1 185 195 19822469
18. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. de Souza GA, Godoy LM, Mann M, Genome Biol 2006 7 8 72 10.1186/gb-2006-7-8-r72 16901338 (Pubitemid 44400344)
19. Characterization of human tear proteome using multiple proteomic analysis techniques. Li N, Wang N, Zheng J, Liu XM, Lever OW, Erickson PM, Li L, J Proteome Res 2005 4 6 2052 2061 10.1021/pr0501970 16335950 (Pubitemid 41814271)
20. Plasminogen activator inhibitor in human tears after laser refractive surgery. Csutak A, Silver DM, Tozser J, Steiber Z, Bagossi P, Hassan Z, Berta A, J Cataract Refract Surg 2008 34 6 897 901 10.1016/j.jcrs.2008.02.024 18498992 (Pubitemid 351699261)
21. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. Zhou L, Beuerman RW, Chan CM, Zhao SZ, Li XR, Yang H, Tong L, Liu S, Stern ME, Tan D, J Proteome Res 2009 8 11 4889 4905 10.1021/pr900686s 19705875
22. Proteome profiling of vitreoretinal diseases by cluster analysis. Shitama T, Hayashi H, Noge S, Uchio E, Oshima K, Haniu H, Takemori N, Komori N, Matsumoto H, Proteomics Clin Appl 2008 2 9 1265 1280 10.1002/prca.200800017 19081814
23. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Klaassen I, Van Noorden CJ, Schlingemann RO, Prog Retin Eye Res 2013 34 19 48 10.1016/j.preteyeres.2013.02.001. Epub 2013 Feb 13 23416119
24. Impact of diabetes on alpha-crystallins and other heat shock proteins in the eye. Heise EA, Fort PE, J Ocul Biol Dis Infor 2011 4 1-2 62 69 23264844
25. Investigation of the human tear film proteome using multiple proteomic approaches. Green-Church KB, Nichols KK, Kleinholz NM, Zhang L, Nichols JJ, Mol Vis 2008 14 456 470 18334958 (Pubitemid 351377320)
26. High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients. Grus FH, Augustin AJ, Eur J Ophthalmol 2001 11 1 19 24 10.1159/000047788 11284480 (Pubitemid 32238625)
27. Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis. Herber S, Grus FH, Sabuncuo P, Augustin AJ, Adv Exp Med Biol 2002 506 623 626 12613970 (Pubitemid 36312998)
28. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic value. Molloy MP, Bolis S, Herbert BR, Ou K, Tyler MI, van Dyk DD, Willcox MD, Gooley AA, Williams KL, Morris CA, et al. Electrophoresis 1997 18 15 2811 2815 10.1002/elps.1150181516 9504814 (Pubitemid 28059953)
29. Analysis of tear proteins by one- and two-dimensional thin-layer iosoelectric focusing, sodium dodecyl sulfate electrophoresis and lectin blotting. Detection of a new component: cystatin C. Reitz C, Breipohl W, Augustin A, Bours J, Graefes Arch Clin Exp Ophthalmol 1998 236 12 894 899 10.1007/s004170050177 9865619 (Pubitemid 28546503)
30. Characterization of the in vivo forms of lacrimal-specific proline-rich proteins in human tear fluid. Fung KY, Morris C, Sathe S, Sack R, Duncan MW, Proteomics 2004 4 12 3953 3959 10.1002/pmic.200300849 15526346 (Pubitemid 39657470)
31. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Grus FH, Podust VN, Bruns K, Lackner K, Fu S, Dalmasso EA, Wirthlin A, Pfeiffer N, Invest Ophthalmol Vis Sci 2005 46 3 863 876 10.1167/iovs.04-0448 15728542 (Pubitemid 41321022)
32. Tear proteomics in evaporative dry eye disease. Versura P, Nanni P, Bavelloni A, Blalock WL, Piazzi M, Roda A, Campos EC, Eye (Lond) 2010 24 8 1396 1402 10.1038/eye.2010.7
33. Proteomic analysis of human tears: defensin expression after ocular surface surgery. Zhou L, Huang LQ, Beuerman RW, Grigg ME, Li SF, Chew FT, Ang L, Stern ME, Tan D, J Proteome Res 2004 3 3 410 416 10.1021/pr034065n 15253421 (Pubitemid 39207344)
34. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. Csosz E, Boross P, Csutak A, Berta A, Toth F, Poliska S, Torok Z, Tozser J, J Proteomics 2012 75 7 2196 2204 10.1016/j.jprot.2012.01.019 22300579
35. Standardization of tear protein determinstions: the effects of sampling, flow rate, and vascular permeability. Berta A, The preocular tear film in health, disease, and contact lens wear Lubbock: Dry Eye Institute, Holly FJ, 1986 418 435
36. Kernlab-An S4 Package for Kernel Methods in R. Karatzoglou A, Hornik K, Smola A, Zeileis A, J Stat Softw 2004 11 9
37. R: A language and environment for statistical computing, http://www.r-project.org/
38. The potential cost of high-throughput proteomics. White FM, Sci Signal 2011 4 160 e8 10.1126/scisignal.2001813 21325204